This secondary analysis of a randomized clinical trial examines plaque measures from coronary computed tomographic angiography to assess the incremental prognostic value of quantitative coronary artery disease measures among symptomatic patients.
This secondary analysis of a randomized clinical trial examines plaque measures from coronary computed tomographic angiography to assess the incremental prognostic value of quantitative coronary artery disease measures among symptomatic patients.